Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation
نویسندگان
چکیده
منابع مشابه
ecg abnormalities after transcatheter aortic valve implantation
transcatheteraortic valve implantation, first introduced in 2002, has been established as an alternative modality for patients deemed not suitable for open-heart surgery. the anatomical vicinity of the atrioventricular node and the his bundle to the non-coronary and rightcoronary aortic cusps predisposes patients to conduction abnormalities in case of severe calcification or mechanical trauma d...
متن کاملOutcome after transvascular transcatheter aortic valve implantation in 2016
Aims We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing transvascular transcatheter aortic valve implantation (TV-TAVI) in comparison to isolated surgical aortic valve replacement (iSAVR) from 2014 to 2016 in Germany. Methods and results All aortic valve procedures performed in Germany are mandatorily registered in a quality control...
متن کاملCognitive trajectory after transcatheter aortic valve implantation.
BACKGROUND Transcatheter aortic valve implantation (TAVI) is known to be associated with silent cerebral injury, which could contribute to cognitive impairment. Considering its increasing use, thorough longitudinal investigation of cognitive trajectory after TAVI is pivotal. METHODS AND RESULTS Repeatable battery for the assessment of neuropsychological status was performed before (E1), 3 day...
متن کاملConduction abnormalities after transcatheter aortic valve implantation
In the last few years, transcatheter aortic valve implantation (TAVI) has become an alternative procedure in patients with severe aortic stenosis and high risk for surgical aortic replacement. Due to the anatomic correlation between aortic valve structure and conduction system of the heart, one of the most common complications after TAVI is conduction system disturbances which including bundle ...
متن کاملTranscatheter Aortic Valve Implantation
A 97-year-old man was referred for assessment to our transcather aortic valve implantation (TAVI) team. He had suffered multiple hospitalizations for heart failure with a signifi cantly elevated BNP at 1830 pg/mL. At the time of assessment, he had grade IV New York Heart Association (NYHA) symptoms. Until recently, he had been working actively, but this had subsequently been severely limited by...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Interventions
سال: 2013
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2013.02.006